Cargando…

P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE

Detalles Bibliográficos
Autores principales: Andemariam, B., Inati, A., Colombatti, R., Minniti, C., Brown, C., Hottmann, M., Gray, S., Hoppe, C., Davis, M., Yue, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430747/
http://dx.doi.org/10.1097/01.HS9.0000848800.77383.3d
_version_ 1784779861322104832
author Andemariam, B.
Inati, A.
Colombatti, R.
Minniti, C.
Brown, C.
Hottmann, M.
Gray, S.
Hoppe, C.
Davis, M.
Yue, P.
author_facet Andemariam, B.
Inati, A.
Colombatti, R.
Minniti, C.
Brown, C.
Hottmann, M.
Gray, S.
Hoppe, C.
Davis, M.
Yue, P.
author_sort Andemariam, B.
collection PubMed
description
format Online
Article
Text
id pubmed-9430747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94307472022-08-31 P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430747/ http://dx.doi.org/10.1097/01.HS9.0000848800.77383.3d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Andemariam, B.
Inati, A.
Colombatti, R.
Minniti, C.
Brown, C.
Hottmann, M.
Gray, S.
Hoppe, C.
Davis, M.
Yue, P.
P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
title P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
title_full P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
title_fullStr P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
title_full_unstemmed P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
title_short P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
title_sort p1486: trials in progress: the thrive studies evaluating the efficacy, safety, and long-term treatment with inclacumab, a p-selectin inhibitor, in patients with sickle cell disease
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430747/
http://dx.doi.org/10.1097/01.HS9.0000848800.77383.3d
work_keys_str_mv AT andemariamb p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT inatia p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT colombattir p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT minnitic p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT brownc p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT hottmannm p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT grays p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT hoppec p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT davism p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease
AT yuep p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease